Andere Sprachen Vivos Therapeutics, Inc.

Aktien

A3EWWY

US92859E2072

VVOS

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:01 03.05.2024			% 5 Tage	% 1. Jan.
2.63 ^USD	0.00%		+1.54%	-78.86%

01.04.	Anzeichen für nachlassende Inflation sorgen für leichte Gewinne bei US-Aktienfutures vorbörslich	MT
01.04.	Top Absteiger vorbörslich	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Vivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical Devices	09.04.
Vivos Therapeutics : rsquo; Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement	09.04.
Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures	01.04.
Top Premarket Decliners	01.04.
Vivos Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Earnings Flash (VVOS) VIVOS THERAPEUTICS Posts Q4 Revenue $3.2M	28.03.
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update	28.03.
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call	28.03.
Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds	15.02.
Vivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions	12.02.
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities	06.02.
Vivos Therapeutics, Inc. Receives FDA Clearance to Vivos Care Oral Appliances to Treat Severe OSA in Adults	06.02.
Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA	08.01.
Vivos Therapeutics, Inc. Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA	08.01.
Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”	11.12.
Top Premarket Decliners	30.11.
Health Care Drops Amid Skepticism About Cigna, Humana Deal -- Health Care Roundup	29.11.
Sector Update: Health Care Stocks Mixed Late Afternoon	29.11.
Top Midday Gainers	29.11.
Sector Update: Health Care Stocks Advance in Afternoon Trading	29.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Vivos Therapeutics, Inc.

Aktien

A3EWWY

US92859E2072

VVOS

Andere Sprachen

Filter